AS03-adjuvanted influenza vaccine in elderly people

The Lancet Infectious Diseases

Volumn 13, Issue 6, 2013, Pages 466-467

  Ledgerwood, Julie E ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; ALPHA TOCOPHEROL; INFLUENZA VACCINE; SQUALENE; WATER OIL CREAM;

DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INFLUENZA A; INFLUENZA A (H3N2); INFLUENZA B; INFLUENZA VACCINATION; LETTER; PNEUMONIA; PRIORITY JOURNAL; SEASONAL INFLUENZA;

ADJUVANTS, IMMUNOLOGIC; ALPHA-TOCOPHEROL; DRUG COMBINATIONS; FEMALE; HUMANS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; POLYSORBATES; SQUALENE;

EID: 84878432684     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(13)70038-0     Document Type: Letter

References (10)

1. Vaccine effectiveness-how well does the flu vaccine work? Centers for Disease Control and Prevention, (accessed Feb 26, 2013). http://www.cdc.gov/flu/about/qa/vaccineeffect.htm.
2. Influenza (seasonal): fact sheet WHO, (accessed Feb 26, 2013). http://www.who.int/mediacentre/factsheets/fs211/en/index.html.
3. Update: influenza activity-United States, September 30, 2012-February 9, 2013 Centers for Disease Control and Prevention, (accessed Feb 26, 2013). http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6207a3.htm?s_cid=mm6207a3_w.
4. Targonski PV, Jacobson RM, Poland GA Immunosenescence: role and measurement in influenza vaccine response among the elderly. Vaccine 2007, 25:3066-3069.
5. Kenney RT, Frech SA, Muenz LR, Villar CP, Glenn GM Dose sparing with intradermal injection of influenza vaccine. N Engl J Med 2004, 351:2295-2301.
6. Diazgranados CA, Dunning AJ, Jordanov E, Landolfi V, Denis M, Talbot HK High-dose trivalent influenza vaccine compared to standard dose vaccine in elderly adults: safety, immunogenicity and relative efficacy during the 2009-2010 season. Vaccine 2013, 31:861-866.
7. McElhaney JE, Beran J, Devaster J-M, et al. AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial. Lancet Infect Dis 2013, published online March 19. http://dx.doi.org/10.1016/S1473-3099(13)70046-X.
8. A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial. Lancet Infect Dis 2011, 11:91-101.
9. Morel S, Didierlaurent A, Bourguignon P, et al. Adjuvant System AS03 containing alpha-tocopherol modulates innate immune response and leads to improved adaptive immunity. Vaccine 2011, 29:2461-2473.
10. Ledgerwood JE, Wei CJ, Hu Z, et al. DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials. Lancet Infect Dis 2011, 11:916-924.